This research presents the development of an innovative electrochemical detection platform using a graphene-zinc oxide (G-ZnO) nanocomposite for the quantification of 17β-estradiol in milk. The G-ZnO nanocomposite, synthesized via a facile one-pot method, exhibited a unique wrinkled structure with a high specific surface area of 143 m²/g. Characterization through SEM, TEM, and XRD confirmed the effective integration of ultrafine ZnO nanoparticles onto graphene sheets. The electrochemical performance of the G-ZnO modified glassy carbon electrode was evaluated, revealing a notably low detection limit of 8.3 nM for 17β-estradiol, a significant improvement over traditional sensors. The sensor demonstrated a wide linear range of 0.05–100 μM and exceptional reproducibility with less than 3.5 % RSD over repeated measurements. Recovery studies in spiked milk samples yielded highly accurate results, with recovery percentages ranging from 97.8 % to 104.6 %. These findings underscore the potential of G-ZnO nanocomposites in creating sensitive, efficient, and reliable sensors for healthcare and environmental applications.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: